Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)
ID: 356212Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356212

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-258.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the Cooperative Agreement mechanism to support a Human Tissue and Organ Research Resource program. This initiative aims to enhance the availability of human tissues and organs for biomedical research, facilitating their procurement, preservation, and distribution to qualified researchers, thereby contributing to the understanding of various diseases and conditions. The program is particularly focused on reducing morbidity and mortality related to disease through robust human tissue research, with a funding cap of $720,000 available over a maximum period of five years. Interested applicants, including higher education institutions and nonprofits, are encouraged to apply starting December 24, 2024, with the first round of funding anticipated to begin on January 24, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-258-Full-Announcement.html
    PAR-24-258.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and its Office of Research Infrastructure Programs (ORIP), has announced a funding opportunity (PAR-24-258) to support a Human Tissue and Organ Research Resource program. This initiative aims to facilitate the procurement, preservation, and distribution of human tissues and organs for biomedical research, enhancing scientists' ability to study various diseases and conditions. The funding mechanism is a cooperative agreement, disallowing clinical trials, with a funding cap of $720,000 over a maximum period of five years. Eligible applicants include higher education institutions, nonprofits, and various government entities, with particular encouragement for those serving underrepresented populations. Applications will undergo a rigorous peer review, assessing significance, investigator qualifications, innovation, approach, and the institutional environment. The overarching goal is to reduce morbidity and mortality related to disease through robust human tissue research, fostering increased collaboration between research institutions and NIH. Key dates include application submission openings on December 24, 2024, and the first round of anticipated funding starting January 24, 2025. Successful applicants must demonstrate prior experience in managing human tissue resources and adherence to strict operational and ethical guidelines.
    Similar Opportunities
    Tissue Chips in Space 2.0: Translational Multi-Organ Tissue Chip Systems for Drug Efficacy, Toxicity Testing, and Personalized Medicine in Human Health, Aging and Associated Diseases (UG3/UH3 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Tissue Chips in Space 2.0," aimed at developing multi-organ microphysiological systems (MPS) to study the effects of microgravity on human health, particularly in relation to aging and associated diseases. This initiative seeks to advance biomedical research by creating automated MPS technologies that replicate human organ functions, with the goal of assessing drug efficacy and safety in low Earth orbit at the International Space Station. The total funding commitment for this project is $5.6 million, and eligible applicants include a diverse range of organizations, such as historically black colleges and universities, tribal colleges, and faith-based organizations. Interested parties should note that the application deadline is October 18, 2024, and can find more information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed)" aimed at supporting the National Institute of Neurological Disorders and Stroke (NINDS) in maintaining and expanding its repository of human cell lines, specifically fibroblast and induced pluripotent stem cells (iPSCs). The initiative seeks to facilitate basic and translational research in neurological disorders by generating new cell lines, ensuring quality assessment standards, and distributing these resources to qualified researchers globally. With a total funding commitment of approximately $1.4 million for fiscal year 2025, eligible applicants include a wide range of organizations, such as educational institutions and non-profits, while proposals focused on non-human cell resources are excluded. Interested parties must submit their applications by October 17, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a non-competitive funding opportunity for a cooperative agreement to support the Human Genetic Cell Repository (HGCR), with a focus on maintaining and distributing a diverse collection of human cell lines and DNA samples for biomedical research. The initiative aims to enhance the repository's capacity by acquiring new cell lines from diverse populations, ensuring ethical practices in sample collection, and promoting inclusivity in research efforts. This funding opportunity provides up to $1.75 million annually for a five-year project period, with applications due by June 10, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the funding announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-055.html.
    Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Resource-Related Research Projects for Development of Animal Models and Related Materials," aimed at advancing research that develops and enhances animal models relevant to human diseases. The initiative seeks applications that demonstrate the need for and potential impact of broadly applicable resources across multiple NIH Institutes and Centers, emphasizing projects that address diseases affecting multiple body systems rather than those focused on specific diseases or singular NIH interests. Eligible applicants include higher education institutions, nonprofit organizations, and government agencies, with funding available up to $5 million per year. The application deadline is set for January 25, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research," aimed at advancing innovative research in biomimetic tissue-engineered technologies for cancer. This initiative seeks to support collaborative, multidisciplinary projects that integrate regenerative medicine, tissue engineering, and cancer biology to develop advanced in vitro and ex vivo models that accurately mimic human cancer pathophysiology. The funding opportunity is crucial for enhancing cancer research methodologies and understanding disease mechanisms, with a maximum budget of $400,000 per year and a project duration of up to five years. Interested applicants must submit their proposals electronically via Grants.gov by May 8, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)" aimed at advancing the development of organ-on-a-chip (OoC) technologies for dental, oral, and craniofacial research. This initiative seeks to support interdisciplinary research that validates these microfluidic systems for disease modeling and pre-clinical efficacy studies, with the goal of establishing OoC technologies as viable alternatives to animal models. A total of $2 million is allocated for 4-5 grants, with individual project budgets capped at $500,000 annually and a project duration of up to five years. Applications are due by November 19, 2024, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering an R21 exploratory/developmental grant aimed at funding innovative research in the development of organ-on-a-chip (OoC) models for dental, oral, and craniofacial (DOC) applications. The primary objective is to validate these microfluidic systems for disease modeling and pre-clinical efficacy studies, promoting a multidisciplinary approach that integrates fields such as bioengineering and computational biology. This initiative is crucial for enhancing drug testing and improving preclinical models, ultimately leading to better clinical trial designs and reducing reliance on animal testing. The total funding available for FY 2025 is $1 million, with individual awards capped at $275,000 over two years. Applications are due by November 19, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)" to support exploratory research utilizing existing biospecimens relevant to heart, lung, and blood diseases. This grant aims to enhance the scientific utility of the NHLBI Biologic Specimen Repository by encouraging researchers to generate preliminary data that can inform future studies, with a focus on maximizing the value of stored collections. A total of $1,155,000 is anticipated for competitive awards from FY2023 through FY2025, with individual budgets capped at $75,000 for a maximum two-year project period. Interested applicants must submit their proposals by December 10, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)" aimed at supporting exploratory research projects that develop innovative technologies to enhance the quality of biospecimens used in cancer research. The initiative focuses on addressing pre-analytical degradation of cancer-relevant biospecimens during collection, processing, and storage, with the goal of improving sample integrity and utility for downstream analyses. This funding is particularly significant for advancing research in cancer biology, early detection, and treatment, while also addressing health disparities. Grants of up to $150,000 are available, with applications opening on March 1, 2024, and a submission deadline of October 1, 2024. For more information, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-010.html.
    Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Early-stage Biomedical Data Repositories and Knowledgebases," aimed at supporting the development of new or significantly modified data repositories and knowledgebases that enhance biomedical research. This initiative encourages applications from a diverse range of eligible organizations, including higher education institutions and non-profits, with a funding cap of $350,000 per year for a maximum project duration of four years. The importance of this funding lies in its potential to align with FAIR data principles, thereby improving the ecosystem for biomedical research. Interested applicants should note that the application period opens on September 30, 2023, with a Notice of Award expected by early 2024; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.